sentences:  Rolapitant has a significantly longer half-life of 160 hours and was approved by the US FDA in 2015.The first registered clinical use of NK1 receptor antagonists was the treatment of emesis, associated with cancer chemotherapy.In 1931, von Euler and Gaddum discovered substance P (SP) in horse brain and intestine.